
|Articles|June 1, 2004
- Pharmaceutical Executive-06-01-2004
June 2004 Table of Contents
June 2004 Table of Contents
Advertisement
Articles in this issue
about 22 years ago
Why Alliances Failabout 22 years ago
Hire Expectationsabout 22 years ago
DTC's Next ChapterAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
5




